Avadel Pharmaceuticals (AVDL) had the highest return in 2000 by a US stock in the Pharmaceuticals Industry, returning 241.2%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Avadel Pharmaceuticals (AVDL) | 2000 | 241.18% |
Nektar Therapeutics (NKTR) | 2000 | 135.57% |
Teva Pharma Industries Ltd ADR (TEVA) | 2000 | 104.5% |
SIGA Technologies (SIGA) | 2000 | 94.23% |
Titan Pharmaceuticals (TTNP) | 2000 | 85.55% |
Bausch Health Companies (BHC) | 2000 | 67.96% |
Eli Lilly and (LLY) | 2000 | 45.17% |
Pfizer (PFE) | 2000 | 44.73% |
Merck (MRK) | 2000 | 38.79% |
Novo Nordisk A-S (NVO) | 2000 | 32.82% |
AstraZeneca PLC ADR (AZN) | 2000 | 32.57% |
Novartis AG ADR (NVS) | 2000 | 31.15% |
Bristol-Myers Squibb (BMY) | 2000 | 16.98% |
Johnson & Johnson (JNJ) | 2000 | 12.82% |
GlaxoSmithKline PLC ADR (GSK) | 2000 | 4.96% |
Cassava Sciences (SAVA) | 2000 | 2.59% |
Viatris (VTRS) | 2000 | 2.32% |
Perrigo (PRGO) | 2000 | -2.57% |
Durect (DRRX) | 2000 | -28.36% |
Assertio Therapeutics (ASRT) | 2000 | -28.57% |
ProPhase Labs (PRPH) | 2000 | -52.29% |
